CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 1 filers reported holding CHEMOCENTRYX INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $16,556,000 | +115.4% | 320,461 | +3.3% | 0.00% | +200.0% |
| Q2 2022 | $7,685,000 | -16.2% | 310,129 | -15.2% | 0.00% | 0.0% |
| Q1 2022 | $9,166,000 | -31.5% | 365,634 | -0.5% | 0.00% | 0.0% |
| Q4 2021 | $13,378,000 | +107.7% | 367,423 | -2.4% | 0.00% | 0.0% |
| Q3 2021 | $6,440,000 | +8.1% | 376,622 | -15.3% | 0.00% | 0.0% |
| Q2 2021 | $5,957,000 | -73.4% | 444,898 | +2.0% | 0.00% | -50.0% |
| Q1 2021 | $22,355,000 | -10.4% | 436,276 | +8.2% | 0.00% | -33.3% |
| Q4 2020 | $24,962,000 | +62.0% | 403,128 | +43.4% | 0.00% | +50.0% |
| Q3 2020 | $15,408,000 | -57.7% | 281,162 | -55.6% | 0.00% | -60.0% |
| Q2 2020 | $36,420,000 | +439.6% | 632,957 | +276.8% | 0.01% | +400.0% |
| Q1 2020 | $6,749,000 | +86.3% | 167,964 | +83.4% | 0.00% | – |
| Q4 2019 | $3,623,000 | -42.1% | 91,600 | -80.1% | 0.00% | -100.0% |
| Q1 2018 | $6,258,000 | +74.0% | 460,141 | -28.9% | 0.00% | 0.0% |
| Q3 2013 | $3,596,000 | -81.0% | 646,800 | -51.8% | 0.00% | -66.7% |
| Q2 2013 | $18,974,000 | – | 1,341,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |